Aliter Capital LLP (Aliter), a specialist investor focused on small to mid-sized UK Support Services businesses, has announced the completion of an investment in FingerPrint Global Ltd (FingerPrint). Aliter is currently investing from its recently announced £134m second fund, Aliter Capital II.
This represents Aliter’s second investment within its ‘Halcyon’ platform which aims to create a market leading, UK-based healthcare-focused software and data analytics group.
FingerPrint is a provider of specialist audit and lifecycle tracking ‘Track & Trace’ solutions related to the sterilisation and decontamination of surgical instruments within clinical environments. The business has an extensive library of procedures, supporting data streams and a proven ability to capture market share through product innovation and longstanding customer relationships.
FingerPrint becomes part of Aliter’s Halcyon platform, joining existing portfolio company Net Solving, a digital health data analytics platform providing web-based data collection systems for clinical audits, disease and patient registries and quality improvement programmes.
PMSI provided the CDD for the deal, including an in-depth assessment of the ‘Track and Trace’ solutions market and FingerPrint’s competitive positioning, as well as a full customer referencing process.
“We chose to work with PMSI given their strong experience in the healthtech space. Gareth and the PMSI team delivered – with clear commercial insights and deep sector knowledge that really informed our investment decision-making.” Gordon Cooper, Group CEO of Halcyon Healthcare
Aliter-backed Halcyon completes investment in FingerPrint (alitercap.com)
Article
PMSI supports Onebright's acquisition of Psicon
Onebright, the UK’s largest private outpatient mental healthcare company, significantly expands its neurodevelopmental services with the acquisition of Psico...